anymedi애니메디솔루션
390110 · KONEX · ₩390110 · 애니메디솔루션
- Market cap
- ₩1.7B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- ROE
- —
- Net margin
- —
Financial statements not available yet. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−93.1% from the high
₩51Today: ₩179 – ₩179₩2,585
Returns
- 1W−55.0%
- 1M−61.1%
- 3M+188.7%
- 6M−60.4%
- YTD−89.5%
- 1Y−88.5%
- Volume today
- 2,175
- 2.5× the 20-day average
- Traded today
- ₩389,325
- Listed shares
- 9,697,047
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
−14.8% on Oct 27, 2026.
We found no news, filing or broker report explaining it yet. Moves without news happen; it may come later.
Possible reasons, not certainties. Not financial advice.
Signals
Normal- BuzzNormalBuzz 48 of 100 (50 is a normal day for this stock).
- MomentumWeak-55.2% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
anymedi stock overview
anymedi (애니메디솔루션, KRX: 390110) is listed on KONEX, in the Medical & precision devices sector. Anymed Solution was founded in 2016 as a spin-off from Asan Medical Center's medical imaging research lab and develops patient-specific surgical solutions that turn medical imaging data into 3D-printed implants, surgical guides, and simulators. Its shares closed at ₩179 on Oct 27, 2026, down 14.76% on the day, giving it a market value of ₩1.7B.
Key facts
- Market cap
- ₩1.7B
- Sector
- Medical & precision devices
- Latest price change
- −14.76%
- As of
- Oct 27, 2026
- Main business
- Anymed Solution was founded in 2016 as a spin-off from Asan Medical Center's medical imaging research lab and develops patient-specific surgical solutions that turn medical imaging data into 3D-printed implants, surgical guides, and simulators.
Quick answers about anymedi
- What does anymedi do?
- Anymed Solution was founded in 2016 as a spin-off from Asan Medical Center's medical imaging research lab and develops patient-specific surgical solutions that turn medical imaging data into 3D-printed implants, surgical guides, and simulators. Its cosmetic AI line includes the Innofit nose implant and a breast cancer partial resection guide, while its medical AI line covers guides for shoulder replacement, orbital fracture, jaw reconstruction, skin and kidney cancer surgery, and a congenital heart disease simulator sold to hospitals. The company's products are designed from each patient's CT or MRI scans using AI and are used in surgery in Korea and beyond.
- What is the market cap of anymedi?
- The market capitalisation of anymedi was ₩1.7B at the close on Oct 27, 2026.
- Who are the largest shareholders of anymedi?
- According to the latest official filings, the largest reported holders are Kim Nam-guk (15.59%, as of Aug 3, 2026); Kim Kook-bae (7.79%, as of Aug 6, 2026).
- When is the next earnings report from anymedi?
- Korean companies rarely announce results dates in advance. Based on when anymedi filed the same report in past years, its next annual results is expected between Mar 20, 2027 and Mar 24, 2027.
Company profile
Anymed Solution was founded in 2016 as a spin-off from Asan Medical Center's medical imaging research lab and develops patient-specific surgical solutions that turn medical imaging data into 3D-printed implants, surgical guides, and simulators. Its cosmetic AI line includes the Innofit nose implant and a breast cancer partial resection guide, while its medical AI line covers guides for shoulder replacement, orbital fracture, jaw reconstruction, skin and kidney cancer surgery, and a congenital heart disease simulator sold to hospitals. The company's products are designed from each patient's CT or MRI scans using AI and are used in surgery in Korea and beyond.
Written by AI from the company's latest annual report.
- Korean name
- 애니메디솔루션
- Themes
- Medical devices
- CEO
- 김국배
- Founded
- Dec 2016
- Listed
- Dec 2022
- Listed shares
- 9,697,047
- Fiscal year ends
- Month 12
- Website
- www.anymedi.com/
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Amended: Insider shareholding reportAug 6, 2026
- 5%+ holding reportAug 5, 2026
- Insider shareholding reportAug 4, 2026
- Insider shareholding reportAug 3, 2026
- Investor relations (IR) eventMay 27, 2026
Titles in Korean until English translations are added.
Also known as: anymedi / 애니메디솔루션 / 390110 / KRX:390110
Source: KRX statistical information